Abstract
Leprosy remains a significant medical and social problem in many developing countries. The varied forms of the disease form a spectrum1. At one pole, tuberculoid leprosy, patients develop high levels of cell-mediated immunity which results in the killing and clearing of bacilli in the tissues. At the lepromatous pole, patients exhibit a selective immunological unresponsiveness to antigens of Mycobacterium leprae so that the organisms inexorably multiply in the skin. We have suggested that in lepromatous leprosy one or a small number of unique antigenic determinants present on M. leprae might induce specific suppressor cells that inhibit the reactivity of helper T-cell clones capable of recognizing other specific or cross reactive determinants2. Although unique epitopes have been identified by monoclonal antibodies on a small number of M. leprae proteins3, the only unique species of antigen present in M. leprae, and not on any other species of mycobacteria so far examined, is a phenolic glycolipid (gly-I)4. We show here that this unique antigen of M. leprae is capable of inducing suppression of mitogenic responses of lepromatous patients' lymphocytes in vitro and provide evidence that the suppressor T cells recognize the specific terminal trisaccharide moiety.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bloom, B. R. & Godal, T. Rev. infect. Dis. 5, 765–780 (1983).
Mehra, V., Mason, L. H., Fields, J. P. & Bloom, B. R. J. Immun. 123, 1813–1817 (1979).
Gillis, T. P. & Buchanan, T. M. Infect. Immun. 37, 172–178 (1982).
Hunter, S. W., Fugiwara, T. & Brennan, P. J. J. biol. Chem. 257, 15072–15078 (1982).
Harboe, M., Closs, O., Bjune, G., Kronvall, G. & Axelsen, N. H. Scand. J. Immun. 9, 111–120 (1978).
Mehra, V. et al. J. Immun. 125, 1183–1188 (1980).
Nath, I., VanRood, J. J., Mehra, N. K. & Vaidya, M. C. Clin. exp. Immun. 42, 203–210 (1980).
Salgame, P. R., Mahadevan, P. R. & Antia, N. H. Infect. Immun. 40, 1119–1126 (1983).
Mehra, V., Convit, J., Rubinstein, A. & Bloom, B. R. J. Immun. 129, 1946–1951 (1982).
Ridley, D. S. & Jopling, W. H. Int. J. Lepr. 34, 255–273 (1966).
Hunter, S. W. & Brennan, P. J. J. biol. Chem. 258, 7556–7562 (1983).
Six, H. R., Young, W. W., Vemura, K. I. & Kinsky, S. C. Biochemistry 13, 4050–4058 (1974).
Convit, J. et al. Int. J. Lepr. 50, 415–424 (1982).
Abebe, H., Godal, T., Mustafa, A. S., Belehu, A. & Yemaneberhan, T. Nature 303, 342–344 (1983).
Baker, P. Transplantn Rev. 26, 3–20 (1975).
Letvin, N. L., Benacerraf, B. & Germain, R. N. Proc. natn. Acad. Sci. U.S.A. 78, 5113–5117 (1981).
Eichmann, K. Eur. J. Immun. 5, 511–517 (1975).
Baer, H. & Chaparas, S. D. Science 146, 245–247 (1964).
Shapiro, M. E., Onderdonk, A. B., Kasper, D. L. & Finberg, R. W. J. exp. Med. 154, 1188–1197 (1982).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mehra, V., Brennan, P., Rada, E. et al. Lymphocyte suppression in leprosy induced by unique M. leprae glycolipid. Nature 308, 194–196 (1984). https://doi.org/10.1038/308194a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/308194a0
This article is cited by
-
Genome analysis identifies a spontaneous nonsense mutation in ppsD leading to attenuation of virulence in laboratory-manipulated Mycobacterium tuberculosis
BMC Genomics (2019)
-
Astonishing diversity of natural surfactants: 3. Carotenoid glycosides and isoprenoid glycolipids
Lipids (2005)
-
A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response
Nature (2004)
-
Chemotherapy of lepromatous leprosy: Recent developments and prospects for the future
European Journal of Clinical Microbiology & Infectious Diseases (1994)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.